An accessible patient-derived xenograft model of low-risk myelodysplastic syndromes

Haematologica. 2024 Jan 1;109(1):337-342. doi: 10.3324/haematol.2023.282967.

Authors

Patric Teodorescu¹, Sergiu Pasca², InYoung Choi², Cynthia Shams², W Brian Dalton², Lukasz P Gondek², Amy E DeZern², Gabriel Ghiaur³

Affiliations

¹ Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD; Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca.
² Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD.
³ Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD. gghiaur1@jhmi.edu.

No abstract available

MeSH terms

Heterografts
Humans
Myelodysplastic Syndromes* / genetics

Grants and funding